{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:44:02Z","timestamp":1792133042303,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s11033-022-07840-0","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T11:02:58Z","timestamp":1660820578000},"page":"9509-9520","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Frequency of germline genetic variants in women with a personal or family history of breast cancer from Brazil"],"prefix":"10.1007","volume":"49","author":[{"given":"J\u00falia Zanon","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Garcia","family":"Carneiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Sousa","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Mattioly","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e2mella Zorzan","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Lins","family":"Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Leonel Vasconcelos","family":"de Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6870-2063","authenticated-orcid":false,"given":"Karina Braga","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,18]]},"reference":[{"key":"7840_CR1","unstructured":"World Health Organization (2020) GLOBOCAN International Agency for Research on Cancer. https:\/\/gco.iarc.fr\/today\/data\/factsheets\/populations\/900-world-fact-sheets.pdf . Accessed 12 Sept 2021"},{"key":"7840_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.2166","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.2166","journal-title":"CA Cancer J Clin"},{"key":"7840_CR3","unstructured":"Instituto Nacional de C\u00e2ncer Jos\u00e9 Alencar Gomes da Silva, INCA (2020) Estimativa 2020: incid\u00eancia do C\u00e2ncer no Brasil. https:\/\/www.inca.gov.br\/sites\/ufu.sti.inca.local\/files\/media\/document\/estimativa-2020-incidencia-de-cancer-no-brasil.pdf. Accessed 12 Sept 2021"},{"key":"7840_CR4","unstructured":"Instituto Nacional de C\u00e2ncer Jos\u00e9 Alencar Gomes da Silva, INCA (2021) Atlas da mortalidade. https:\/\/www.inca.gov.br\/app\/mortalidade. Accessed 12 Sept 2021"},{"key":"7840_CR5","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1590\/S0034-71672011000600005","volume":"64","author":"PA Silva","year":"2011","unstructured":"Silva PA, Riul SS (2011) C\u00e2ncer de mama: fatores de risco e detec\u00e7\u00e3o precoce. Rev Bras Enferm 64:1016\u20131021. https:\/\/doi.org\/10.1590\/S0034-71672011000600005","journal-title":"Rev Bras Enferm"},{"key":"7840_CR6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.21877\/2448-3877.201800615","volume":"51","author":"LCB Amendola","year":"2005","unstructured":"Amendola LCB, Vieira R (2005) BRCA genes contribution in the hereditary predisposition for breast cancer. RBAC 51:325\u2013330. https:\/\/doi.org\/10.21877\/2448-3877.201800615","journal-title":"RBAC"},{"key":"7840_CR7","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1126\/science.1251827","volume":"343","author":"FJ Couch","year":"2014","unstructured":"Couch FJ, Nathanson KL, Offit K (2014) Two decades after BRCA: setting paradigms in personalized cancer care and prevention. Science 343:1466\u20131470. https:\/\/doi.org\/10.1126\/science.1251827","journal-title":"Science"},{"key":"7840_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","volume":"5","author":"N Harbeck","year":"2019","unstructured":"Harbeck N, Penault-Llorca F, Cortes J et al (2019) Breast cancer. Nat Rev Dis Primers 5:66. https:\/\/doi.org\/10.1038\/s41572-019-0111-2","journal-title":"Nat Rev Dis Primers"},{"key":"7840_CR9","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s10549-020-05985-9","volume":"185","author":"R Gomes","year":"2021","unstructured":"Gomes R, Spinola PS, Brant AC et al (2021) Prevalence of germline variants in consensus moderate-to-high-risk predisposition genes to hereditary breast and ovarian c\u00e2ncer in BRCA1\/2-negative Brazilian patients. Breast Cancer Res Treat 185:851\u2013861. https:\/\/doi.org\/10.1007\/s10549-020-05985-9","journal-title":"Breast Cancer Res Treat"},{"key":"7840_CR10","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1177\/1947601911413466","volume":"2","author":"D Malkin","year":"2011","unstructured":"Malkin D (2011) Li Fraumeni syndrome. Genes Cancer 2:475\u2013484. https:\/\/doi.org\/10.1177\/1947601911413466","journal-title":"Genes Cancer"},{"key":"7840_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jnci\/djh034","volume":"96","author":"A Umar","year":"2004","unstructured":"Umar A, Boland CR, Terdiman JP et al (2004) Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. JNCI 96:261\u2013268. https:\/\/doi.org\/10.1093\/jnci\/djh034","journal-title":"JNCI"},{"key":"7840_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ccr.2007.01.010","volume":"11","author":"T Walsh","year":"2007","unstructured":"Walsh T, King MC (2007) Ten genes for inherited breast cancer. Cancer Cell 11:103\u2013105. https:\/\/doi.org\/10.1016\/j.ccr.2007.01.010","journal-title":"Cancer Cell"},{"key":"7840_CR13","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s10549-018-4938-0","volume":"172","author":"ARS Timoteo","year":"2018","unstructured":"Timoteo ARS, Gon\u00e7alves AEMM, Sales LAP et al (2018) A portrait of germline mutation in Brazilian at-risk for hereditary breast cancer. Breast Cancer Res Treat 172:637\u2013646. https:\/\/doi.org\/10.1007\/s10549-018-4938-0","journal-title":"Breast Cancer Res Treat"},{"key":"7840_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12920-019-0652-y","volume":"13","author":"SCS Carvalho","year":"2020","unstructured":"Carvalho SCS, Cury NM, Brotto DB et al (2020) Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population. BMC Med Genomics 13:1\u201324. https:\/\/doi.org\/10.1186\/s12920-019-0652-y","journal-title":"BMC Med Genomics"},{"key":"7840_CR15","unstructured":"Instituto Nacional do C\u00e2ncer Jos\u00e9 Alencar Gomes da Silva, INCA (2008) A\u00e7\u00f5es de enfermagem para o controle do c\u00e2ncer. https:\/\/www.inca.gov.br\/publicacoes\/livros\/acoes-de-enfermagem-para-o-controle-do-cancer. Accessed 14 Sept 2021"},{"key":"7840_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.5327\/Z201400040002RBM","volume":"24","author":"NJS Barreto-Neto","year":"2014","unstructured":"Barreto-Neto NJS, Pinheiro AB, Oliveira JF et al (2014) Perfil epidemiol\u00f3gico dos subtipos moleculares de carcinoma ductal da mama em popula\u00e7\u00e3o de pacientes em Salvador, Bahia. Rev Bras Mastologia 24:98\u2013102","journal-title":"Rev Bras Mastologia"},{"key":"7840_CR17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3389\/fonc.2015.00208","volume":"5","author":"TP Slavin","year":"2015","unstructured":"Slavin TP, Niell-Swiller M, Solomon I et al (2015) Clinical application of multigene panels: challenges of next-generation counseling and cancer risk management. Front Oncol 5:208. https:\/\/doi.org\/10.3389\/fonc.2015.00208","journal-title":"Front Oncol"},{"key":"7840_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.21877\/2448-3877.201800615","volume":"50","author":"AS Coelho","year":"2018","unstructured":"Coelho AS, Santos MAS, Caetano RI et al (2018) Predisposi\u00e7\u00e3o heredit\u00e1ria ao c\u00e2ncer de mama e sua rela\u00e7\u00e3o com os genes BRCA1 e BRCA2: revis\u00e3o da literatura. RBAC 50:17\u201321. https:\/\/doi.org\/10.21877\/2448-3877.201800615","journal-title":"RBAC"},{"key":"7840_CR19","volume-title":"Thompson & Thompson Gen\u00e9tica M\u00e9dica","author":"R Nussbaum","year":"2016","unstructured":"Nussbaum R, Mcinnes RR, Willard HF (2016) Thompson & Thompson Gen\u00e9tica M\u00e9dica. Elsevier Editora Ltda, S\u00e3o Paulo"},{"key":"7840_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0092-8674(02)00615-3","volume":"108","author":"AR Venkitaraman","year":"2002","unstructured":"Venkitaraman AR (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108:171\u2013182. https:\/\/doi.org\/10.1016\/S0092-8674(02)00615-3","journal-title":"Cell"},{"key":"7840_CR21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10689-004-9550-2","volume":"3","author":"WS Rubinstein","year":"2004","unstructured":"Rubinstein WS (2004) Hereditary breast cancer in Jews. Fam Cancer 3:249\u2013257. https:\/\/doi.org\/10.1007\/s10689-004-9550-2","journal-title":"Fam Cancer"},{"key":"7840_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/928562","author":"F Karami","year":"2013","unstructured":"Karami F, Mehdipour P (2013) A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer. Biomed Res Int. https:\/\/doi.org\/10.1155\/2013\/928562","journal-title":"Biomed Res Int"},{"key":"7840_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.canlet.2007.10.044","volume":"261","author":"EI Palmero","year":"2008","unstructured":"Palmero EI, Schuler-Faccini L, Caleffi M et al (2008) Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil. Cancer Lett 261:21\u201325. https:\/\/doi.org\/10.1016\/j.canlet.2007.10.044","journal-title":"Cancer Lett"},{"key":"7840_CR24","doi-asserted-by":"publisher","DOI":"10.1590\/\/1678-4685-GMB-2019-0072","author":"R Gomes","year":"2020","unstructured":"Gomes R, Soares BL, Felicio OS et al (2020) Haplotypic characterization of BRCA1 c. 5266dupC, the prevailing mutation in Brazilian hereditary breast\/ovarian cancer. Genet Mol Biol. https:\/\/doi.org\/10.1590\/\/1678-4685-GMB-2019-0072","journal-title":"Genet Mol Biol"},{"key":"7840_CR25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/351453a0","volume":"6","author":"AJ Levine","year":"1991","unstructured":"Levine AJ, Momand J, Finlay CA (1991) The p53 tumour suppressor gene. Nature 6:453\u2013466. https:\/\/doi.org\/10.1038\/351453a0","journal-title":"Nature"},{"key":"7840_CR26","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1002\/cncr.33143","volume":"126","author":"EM Pinto","year":"2020","unstructured":"Pinto EM, Zambetti GP (2020) What 20 years of research has taught us about the TP53 p. R337H mutation. Cancer 126:4678\u20134686. https:\/\/doi.org\/10.1002\/cncr.33143","journal-title":"Cancer"},{"key":"7840_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-8-357","volume":"8","author":"JG Assump\u00e7\u00e3p","year":"2008","unstructured":"Assump\u00e7\u00e3p JG, Seidinger AL, Mastellaro MJ et al (2008) Association of the germline TP53 R337H mutation with breast cancer in southern Brazil. BMC Cancer 8:1\u20136. https:\/\/doi.org\/10.1186\/1471-2407-8-357","journal-title":"BMC Cancer"},{"key":"7840_CR28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1371\/journal.pone.0099893","volume":"9","author":"J Giacomazzi","year":"2014","unstructured":"Giacomazzi J, Graudenz MS, Osorio CA et al (2014) Prevalence of the TP53 P.R337H Mutation in Breast Cancer Patients in Brazil. PLoS ONE 9:6. https:\/\/doi.org\/10.1371\/journal.pone.0099893","journal-title":"PLoS ONE"},{"key":"7840_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/hgv.2014.12","volume":"1","author":"GE Felix","year":"2014","unstructured":"Felix GE, Abe-Sandes C, Machado-Lopes TM et al (2014) Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a northeast Brazilian population. Hum Genome Var 1:1\u20138. https:\/\/doi.org\/10.1038\/hgv.2014.12","journal-title":"Hum Genome Var"},{"key":"7840_CR30","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","volume":"21","author":"G Bougeard","year":"2015","unstructured":"Bougeard G, Renaux-Petel M, Flaman JM et al (2015) Revisiting Li\u2013Fraumeni syndrome from TP53 mutation carriers. J Clin Oncol 21:2345\u20132352. https:\/\/doi.org\/10.1200\/JCO.2014.59.5728","journal-title":"J Clin Oncol"},{"key":"7840_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/CCO.0000000000000423","volume":"1","author":"A Amadou","year":"2018","unstructured":"Amadou A, Achatz MIW, Hainaut P (2018) Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li\u2013Fraumeni syndrome. Curr Opin Oncol 1:23\u201329. https:\/\/doi.org\/10.1097\/CCO.0000000000000423","journal-title":"Curr Opin Oncol"},{"key":"7840_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.canlet.2005.12.039","volume":"245","author":"MI Achatz","year":"2007","unstructured":"Achatz MI, Olivier M, Le Calvez F et al (2007) The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families. Cancer Lett 245:96\u2013102. https:\/\/doi.org\/10.1016\/j.canlet.2005.12.039","journal-title":"Cancer Lett"},{"key":"7840_CR33","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1200\/JCO.2012.46.3711","volume":"31","author":"G Cust\u00f3dio","year":"2013","unstructured":"Cust\u00f3dio G, Parise GA, Kiesel NF et al (2013) Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors. J Clin Oncol 31:2619. https:\/\/doi.org\/10.1200\/JCO.2012.46.3711","journal-title":"J Clin Oncol"},{"key":"7840_CR34","doi-asserted-by":"publisher","first-page":"743231","DOI":"10.3389\/fonc.2021.743231","volume":"11","author":"D Barbalho","year":"2021","unstructured":"Barbalho D, Sandoval R, Santos E et al (2021) Novel insights from the germline landscape of breast cancer in Brazil. Front Oncol 11:743231\u2013743231. https:\/\/doi.org\/10.3389\/fonc.2021.743231","journal-title":"Front Oncol"},{"key":"7840_CR35","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3389\/fonc.2022.836937","volume":"12","author":"RL Sandoval","year":"2022","unstructured":"Sandoval RL, Polidorio N, Leite ACR et al (2022) Breast cancer phenotype associated with Li-Fraumeni syndrome: a Brazilian cohort enriched by TP53 p. R337H carriers. Front Oncol 12:826. https:\/\/doi.org\/10.3389\/fonc.2022.836937","journal-title":"Front Oncol"},{"key":"7840_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-07383-1","volume":"12","author":"RSC Guindalini","year":"2022","unstructured":"Guindalini RSC, Viana DV, Kitajima JPFW et al (2022) Detection of germline variants in Brazilian breast cancer patients using multigene panel testing. Sci Rep 12:1\u201312. https:\/\/doi.org\/10.1038\/s41598-022-07383-1","journal-title":"Sci Rep"},{"key":"7840_CR37","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/jnci\/dji141","volume":"97","author":"D Thompson","year":"2005","unstructured":"Thompson D, Duedal S, Kirner J et al (2005) Cancer risks and mortality in heterozygous ATM mutation carriers. JNCI 97:813\u2013822. https:\/\/doi.org\/10.1093\/jnci\/dji141","journal-title":"JNCI"},{"key":"7840_CR38","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","volume":"33","author":"FJ Couch","year":"2015","unstructured":"Couch FJ, Hart SN, Sharma P et al (2015) Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J Clin Oncol 33:304. https:\/\/doi.org\/10.1200\/JCO.2014.57.1414","journal-title":"J Clin Oncol"},{"key":"7840_CR39","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1200\/JCO.2010.34.0778","volume":"29","author":"C Cybulski","year":"2011","unstructured":"Cybulski C, Wokolorczyk D, Jakubowska A et al (2011) Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer. J Clin Oncol 29:3747\u20133752. https:\/\/doi.org\/10.1200\/JCO.2010.34.0778","journal-title":"J Clin Oncol"},{"key":"7840_CR40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/ng1959","volume":"39","author":"N Rahman","year":"2007","unstructured":"Rahman N, Seal S, Thompson D et al (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39:165\u2013167. https:\/\/doi.org\/10.1038\/ng1959","journal-title":"Nat Genet"},{"key":"7840_CR41","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1158\/1078-0432.CCR-08-3128","volume":"15","author":"T Heikkinen","year":"2009","unstructured":"Heikkinen T, Karkkainen H, Aaltonen K et al (2009) The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype. Clin Cancer Res 15:3214\u20133222. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-3128","journal-title":"Clin Cancer Res"},{"key":"7840_CR42","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/sj.ejhg.5201584","volume":"14","author":"HT Lynch","year":"2006","unstructured":"Lynch HT, Boland CR, Gong G et al (2006) Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications. Eur J Hum Genet 14:390\u2013402. https:\/\/doi.org\/10.1038\/sj.ejhg.5201584","journal-title":"Eur J Hum Genet"},{"key":"7840_CR43","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013423. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"7840_CR44","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1200\/JCO.2013.53.6607","volume":"32","author":"AW Kurian","year":"2014","unstructured":"Kurian AW, Hare EE, Mills MA et al (2014) Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment. J Clin Oncol 32:2001. https:\/\/doi.org\/10.1200\/JCO.2013.53.6607","journal-title":"J Clin Oncol"},{"key":"7840_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cncr.29010","volume":"121","author":"N Tung","year":"2015","unstructured":"Tung N, Battelli C, Allen B et al (2015) Frequency of mutations in individuals with breast cancer referred for BRCA 1 and BRCA 2 testing using next-generation sequencing with a 25-gene panel. Cancer 121:25\u201333. https:\/\/doi.org\/10.1002\/cncr.29010","journal-title":"Cancer"},{"key":"7840_CR46","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/humu.20897","volume":"29","author":"DE Goldgar","year":"2008","unstructured":"Goldgar DE, Easton DF, Graham BB et al (2008) Genetic evidence and integration of various data sources for classifying uncertain variants into a single model. Hum Mutat 29:1265\u20131272. https:\/\/doi.org\/10.1002\/humu.20897","journal-title":"Hum Mutat"},{"key":"7840_CR47","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","volume":"19","author":"MM Li","year":"2017","unstructured":"Li MM, Datto M, Duncavage EJ et al (2017) Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn 19:4\u201323. https:\/\/doi.org\/10.1016\/j.jmoldx.2016.10.002","journal-title":"J Mol Diagn"},{"key":"7840_CR48","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1200\/JCO.2009.27.0660","volume":"33","author":"ME Robson","year":"2010","unstructured":"Robson ME, Storm CD, Weitzel J, Wollins DS, Ofitt K (2010) American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol 33:3660\u20133667. https:\/\/doi.org\/10.1200\/JCO.2009.27.0660","journal-title":"J Clin Oncol"},{"key":"7840_CR49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cancergen.2019.06.005","volume":"237","author":"I Carnevali","year":"2019","unstructured":"Carnevali I, Riva C, Chiaravalli AM et al (2019) Inherited cancer syndromes in 220 Italian ovarian cancer patients. Cancer Genet 237:55\u201362. https:\/\/doi.org\/10.1016\/j.cancergen.2019.06.005","journal-title":"Cancer Genet"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07840-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-07840-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07840-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T12:19:57Z","timestamp":1664281197000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-07840-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,18]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["7840"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-07840-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,18]]},"assertion":[{"value":"28 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics Comitte of Federal University of Minas Gerais (CAAE- 54070121.0.0000.5149).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}